B Cell Response Induced by SARS-CoV-2 Infection Is Boosted by the BNT162b2 Vaccine in Primary Antibody Deficiencies

Background: Patients with primary antibody deficiencies are at risk in the current COVID-19 pandemic due to their impaired response to infection and vaccination. Specifically, patients with common variable immunodeficiency (CVID) generated poor spike-specific antibody and T cell responses after immu...

Descripción completa

Detalles Bibliográficos
Autores principales: Pulvirenti, Federica, Fernandez Salinas, Ane, Milito, Cinzia, Terreri, Sara, Piano Mortari, Eva, Quintarelli, Concetta, Di Cecca, Stefano, Lagnese, Gianluca, Punziano, Alessandra, Guercio, Marika, Bonanni, Livia, Auria, Stefania, Villani, Francesca, Albano, Christian, Locatelli, Franco, Spadaro, Giuseppe, Carsetti, Rita, Quinti, Isabella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616496/
https://www.ncbi.nlm.nih.gov/pubmed/34831138
http://dx.doi.org/10.3390/cells10112915

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616496/
https://www.ncbi.nlm.nih.gov/pubmed/34831138
http://dx.doi.org/10.3390/cells10112915

Ejemplares similares